David Kirn Insider Profile
4 Followers
David Kirn, President & CEO, Director at 4D Molecular Therapeutics, holds 942.49K shares in 4D Molecular Therapeutics (Ticker: FDMT).
David Kirn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that David Kirn holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by David Kirn
David Kirn's Trading History
List of latest transactions for each holding click on a transaction to see David Kirn's performance on stock
You May Also Like
David Kirn insider profile FAQ
What is the percentage of profitable transactions made by David Kirn?
The percentage of profitable transactions made by David Kirn is ―.
What is the average return per transaction made by David Kirn?
The average return per transaction made by David Kirn is ―.
What stocks does David Kirn hold?
David Kirn holds: FDMT stocks.
What was David Kirn’s latest transaction?
David Kirn latest transaction was an Uninformative Sell of $1.20M.
What was David Kirn's most profitable transaction?
David Kirn’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is David Kirn's role in 4D Molecular Therapeutics?
David Kirn's role in 4D Molecular Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.